Skip to main content
Log in

Decreased serum interleukin 27 in Brazilian systemic lupus erythematosus patients

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

The immunological role of interleukin 27 has been reported in various inflammatory diseases, but its importance in systemic lupus erythematosus pathogenesis is not completely established. The aim of this study was to evaluate serum levels of IL-27 in SLE patients and its correlation with clinical manifestations and disease activity. IL-27 levels were assessed in 70 SLE patients and 30 healthy controls by ELISA. Clinical and laboratory parameters were recorded. Statistic analyzes were performed by Graph Prism 3.02 software. The IL-27 serum levels were significantly decreased in SLE patients compared with controls (mean 899.92 and 1,531.22 pg/ml, P = 0.0005). There was a correlation between IL-27 levels and C3 levels (P = 0.004). Nevertheless, there was no association of serum IL-27 levels with disease activity evaluated by SLEDAI score (P = 0.9605). No significant difference was found regarding IL-27 levels between SLE patients with and without nephritis, haematuria, proteinuria and positive anti-dsDNA. Correlation analysis between serum IL-27 levels and SLEDAI, SLICC, proteinuria levels, C4 and CH50 levels also showed no association. These data demonstrated decreased serum levels of IL-27 in SLE patients but further studies are needed to clarify the precise role of this cytokine and its potential use as therapeutic target.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Yap DY, Lai KN (2010) Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances. J Biomed Biotechnol 2010:365083

    Article  PubMed  Google Scholar 

  2. Amel-Kashipaz MR, Huggins ML, Lanyon P et al (2001) Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(−) and CD8(+) T cells in systemic lupus erythematosus. J Autoimmun 17(2):155–163

    Article  PubMed  CAS  Google Scholar 

  3. Chen DY, Chen YM, Wen MC, et al (2012) The potential role of Th17 cells and Th17-related cytokines in the pathogenesis of lupus nephritis. Lupus. 2012 Aug 14. [Epub ahead of print]

  4. Zhao XF, Pan HF, Yuan H et al (2010) Increased serum interleukin 17 in patients with systemic lupus erythematosus. Mol Biol Rep 37:81–85

    Article  PubMed  Google Scholar 

  5. Pflanz S, Timans JC, Cheung J et al (2002) IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 16(6):779–790

    Google Scholar 

  6. Villarino AV, Stumhofer JS, Saris CJ, Kastelein RA, de Sauvage FJ, Hunter CA (2006) IL-27 limits IL-2 production during Th1 differentiation. J Immunol 176(1):237–247

    PubMed  CAS  Google Scholar 

  7. Liu H, Rohowsky-Kochan C (2011) Interleukin-27-mediated suppression of human Th17 cells is associated with activation of STAT1 and suppressor of cytokine signaling protein 1. J Interferon Cytokine Res 31(5):459–469

    Article  CAS  Google Scholar 

  8. Awasthi A, Carrier Y, Peron JP et al (2007) A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol 8(12):1380–1389

    Article  PubMed  CAS  Google Scholar 

  9. Shen H, Xia L, Xiao W, Lu J (2011) Increased levels of interleukin-27 in patients with rheumatoid arthritis. Arthritis Rheum 63(3):860–861

    Article  PubMed  CAS  Google Scholar 

  10. Yoshizaki A, Yanaba K, Iwata Y et al (2011) Elevated serum interleukin-27 levels in patients with systemic sclerosis: association with T cell, B cell and fibroblast activation. Ann Rheum Dis 70(1):194–200

    Article  PubMed  CAS  Google Scholar 

  11. Shibata S, Tada Y, Kanda N et al (2010) Possible roles of IL-27 in the pathogenesis of psoriasis. J Invest Dermatol 130(4):1034–1039

    Article  PubMed  CAS  Google Scholar 

  12. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725

    Article  PubMed  CAS  Google Scholar 

  13. Gladman DD, Ibanez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29(2):288–291

    PubMed  Google Scholar 

  14. Sugiyama N, Nakashima H, Yoshimura T et al (2008) Amelioration of human lupus-like phenotypes in MRL/lpr mice by overexpression of interleukin 27 receptor alpha (WSX-1). Ann Rheum Dis 67(10):1461–1467

    Article  PubMed  CAS  Google Scholar 

  15. Li TT, Zhang T, Chen GM et al (2010) Low level of serum interleukin 27 in patients with systemic lupus erythematosus. J Investig Med 58(5):737–739

    PubMed  CAS  Google Scholar 

  16. Shimizu S, Sugiyama N, Masutani K et al (2005) Membranous glomerulonephritis development with Th2-type immune deviations in MRL/lpr mice deficient for IL-27 receptor (WSX-1). J Immunol 175(11):7185–7192

    PubMed  CAS  Google Scholar 

  17. Igawa T, Nakashima H, Sadanaga A et al (2009) Deficiency in EBV-induced gene 3 (EBI3) in MRL/lpr mice results in pathological alteration of autoimmune glomerulonephritis and sialadenitis. Mod Rheumatol 19(1):33–41

    Article  PubMed  CAS  Google Scholar 

  18. Kwan BC, Tam LS, Lai KB et al (2009) The gene expression of type 17 T-helper cell-related cytokines in the urinary sediment of patients with systemic lupus erythematosus. Rheumatology (Oxford) 48(12):1491–1497

    Article  CAS  Google Scholar 

  19. Wong CK, Ho CY, Li EK et al (2000) Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 9:589–593

    Article  PubMed  CAS  Google Scholar 

  20. Yoshimura T, Takeda A, Hamano S et al (2006) Two-sided roles of IL-27: induction of Th1 differentiation on naive CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism. J Immunol 177:5377–5385

    PubMed  CAS  Google Scholar 

  21. Diveu C, McGeachy MJ, Boniface K et al (2009) IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells. J Immunol 182:5748–5756

    Article  PubMed  CAS  Google Scholar 

  22. Murugaiyan G, Mittal A, Lopez-Diego R et al (2009) IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells. J Immunol 183(4):2435–2443

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This is study was supported by the Instituto Nacional de Ciência e Tecnologia para Inovação Farmacêutica (INCT_if), Fundação de Amparo à Ciência e Tecnologia do Estado de Pernambuco (FACEPE) and Financiadora de Estudos e Projetos (FINEP).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maira Galdino da Rocha Pitta.

Additional information

Angela Luzia Branco Pinto Duarte, Andréa Tavares Dantas are contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Duarte, A.L.B.P., Dantas, A.T., de Ataíde Mariz, H. et al. Decreased serum interleukin 27 in Brazilian systemic lupus erythematosus patients. Mol Biol Rep 40, 4889–4892 (2013). https://doi.org/10.1007/s11033-013-2588-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-013-2588-1

Keywords

Navigation